ResearcherActive in the last 2 years

Lisa Knoll

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-6622-180X; OpenAlex author ID A5012132902. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2024: 1 paper

Papers 1

Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing. Co-author DOI 10.1016/j.neo.2024.101002 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Robert G. Goetze · 1 shared paper, 2024 · strength 0.21
- Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002 ↗
Shiv K. Singh · 1 shared paper, 2024 · strength 0.21
- Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002 ↗
Christoph Ammer‐Herrmenau · 1 shared paper, 2024 · strength 0.21
- Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002 ↗
Albrecht Neeße · 1 shared paper, 2024 · strength 0.21
- Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002 ↗
Elisabeth Heßmann · 1 shared paper, 2024 · strength 0.21
- Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002 ↗
Volker Ellenrieder · 1 shared paper, 2024 · strength 0.21
- Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.